CompletedPhase 1

Oral Bioavailability of Two Solid Formulations of GLPG0259.

Belgium12 participantsStarted 2010-11

Plain-language summary

The purpose of the study is to evaluate the relative bioavailability of two solid oral formulations of GLPG0259 administered after a meal.

Who can participate

Age range18 Years – 50 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * healthy male, age 18-50 years * BMI between 18-30 kg/m², inclusive. Exclusion Criteria: * significantly abnormal platelet function or coagulopathy * smoking * drug or alcohol abuse

What they're measuring

Bioavailability of two solid dosage formulations of GLPG0259

Timeframe: up to 96 hours postdose

Trial details

NCT IDNCT01322451

SponsorGalapagos NV

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2010-12

View on ClinicalTrials.gov More Healthy trials